首页 正文

Testosterone Therapy for the Treatment of Age-Related Hypogonadism: Risks with Uncertain Benefits

{{output}}
Testosterone replacement therapy has been approved in the United States since the 1950s for men with "classical" hypogonadism. These men have specific and well-recognized hypothalamic, pituitary, or testicular conditions leading to deficient or absent endogeno... ...